Inhibition of clot formation process by treatment with the lowmolecular-weight heparin nadroparin in patients with carotid artery disease undergoing angioplasty and stenting - A thromboelastography study on whole blood
Open Access
- 1 January 2007
- journal article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 97 (01), 109-118
- https://doi.org/10.1160/th05-10-0701
Abstract
Low-molecular-weight heparins (LMWHs) have become the corner stone of antithrombotic treatment but their administration protocol needs to be optimized for certain groups of patients. In this paper, we studied the influence of nadroparin treatment on clot formation process assessed by thromboelastography in patients with carotid artery disease undergoing angioplasty and stenting. Standard thromboelastography assays (in-TEM® and ex-TEM® ) and minimal TF-triggered thromboelastography assay in citrated whole blood were performed in normal volunteers (n=20), in patients with carotid artery disease receiving only antiplatelet treatment (n=30), and in patients undergoing angioplasty receiving nadroparin 5750 anti-Xa IU s.c. twice daily (n=60). Blood samples were collected four hours after a second injection of nadroparin. In a subgroup of LMWH-patients (n=18) blood samples were also obtained prior to first injection of LMWH. Antiplatelet treatment had no effect on any parameter of the thromboelastographic pattern. Nadroparin treatment resulted in significant prolongation of clotting time (CT) and clot formation time (CFT) and significantly reduced α-angle in minimal TF-triggered thromboelastography and 30–38% of nadroparin treated patients had thromboelastographic parameters beyond the normal maximum limit. In-TEM test revealed a significant prolongation of clotting time while ex-TEM was not modified, and 20 to 30% of the patients had thromboelastographic parameters beyond the normal maximum limit. Anti factor-Xa activity in platelet-poor plasma (PPP) was also measured, and statistical analysis showed that prolongation of CFT of minimal TF-triggered TEM was significantly correlated to the levels of anti-Xa activity in patients’ plasma (p=0.04; r2 =0.7). There was no statistical correlation for any other parameter in all tests. In conclusion, the present study shows that nadroparin treatment in patients with carotid artery disease undergoing endovascular procedures induces significant modification of the thrombus kinetics assessed by minimal TF-triggered whole blood thromboelastography. The clinical relevance of these findings has to be evaluated in future studies.This publication has 42 references indexed in Scilit:
- Fixed dosage of low‐molecular‐weight heparins causes large individual variation in coagulability, only partly correlated to body weightJournal of Thrombosis and Haemostasis, 2006
- Safety Profile of Different Low-Molecular Weight Heparins Used at Therapeutic DoseDrug Safety, 2005
- In vitro comparison of the effect of fondaparinux and enoxaparin on whole blood tissue factor-triggered thromboelastography profileThrombosis and Haemostasis, 2004
- The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formationThrombosis and Haemostasis, 2004
- Early Outcome of Carotid Angioplasty and Stenting With and Without Cerebral Protection DevicesStroke, 2003
- Occurrence of thrombosis and haemorrhage, relationship with anti‐Xa, anti‐IIa activities, and D‐dimer plasma levels in patients receiving a low molecular weight heparin, enoxaparin or tinzaparin, to prevent deep vein thrombosis after hip surgeryBritish Journal of Haematology, 1999
- Thromboelastography-Guided Transfusion Algorithm Reduces Transfusions in Complex Cardiac SurgeryAnesthesia & Analgesia, 1999
- Low-Molecular-Weight HeparinsNew England Journal of Medicine, 1997
- Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial)Journal of the American College of Cardiology, 1996
- Blutgerinnungsstudien mit der Thrombelastographie, einem neuen UntersuchungsverfahrenJournal of Molecular Medicine, 1948